Original Research

Published on 04 May 2022

Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models

in Cancer Molecular Targets and Therapeutics

Diana Canals Hernaez
Michael R. Hughes
Yicong Li
Ilaria Mainero Rocca
Pamela Dean
Julyanne Brassard
Erin M. Bell
Ismael Samudio
Anne-Marie Mes-Masson
Yoshiki Narimatsu

Frontiers in Oncology

doi 10.3389/fonc.2022.856424

5,090 views
7 citations

Original Research

Published on 02 May 2022

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC

in Cancer Molecular Targets and Therapeutics

Lingyi Zhou
Zheng Fu
Shuai Wang
Jing Jia
Yumeng Cheng
Yunxiang Zheng
Ningning Zhang
Wei Lu
Zhi Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.875097

4,327 views
5 citations

General Commentary

Published on 02 May 2022

Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential

in Cancer Molecular Targets and Therapeutics

Uffe Ravnskov
Kilmer S. McCully

Frontiers in Oncology

doi 10.3389/fonc.2022.891352

2,869 views
1 citation

Original Research

Published on 28 Apr 2022

A Combined Effect of G-Quadruplex and Neuro-Inducers as an Alternative Approach to Human Glioblastoma Therapy

in Cancer Molecular Targets and Therapeutics

Galina Pavlova
Varvara Kolesnikova
Nadezhda Samoylenkova
Sergey Drozd
Alexander Revishchin
Dzhirgala Shamadykova
Dmitry Y. Usachev
Alexey Kopylov

Frontiers in Oncology

doi 10.3389/fonc.2022.880740

2,575 views
5 citations

Original Research

Published on 28 Apr 2022

Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression

in Cancer Molecular Targets and Therapeutics

Christopher A. Lucchesi
Jin Zhang
Demitria M. Vasilatis
Elizabeth Yip
Xinbin Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.893062

1,842 views
2 citations

Mini Review

Published on 28 Apr 2022

Transfer RNA-Derived Small RNAs: Novel Regulators and Biomarkers of Cancers

in Cancer Molecular Targets and Therapeutics

Bi-Fei Fu
Chao-Yang Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.843598

3,717 views
11 citations

Original Research

Published on 28 Apr 2022

Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases

in Cancer Molecular Targets and Therapeutics

Xi Wu
Puyuan Xing
Min Shi
Weihua Guo
Fangping Zhao
Honglin Zhu
Jianping Xiao
Jinghai Wan
Junling Li

Frontiers in Oncology

doi 10.3389/fonc.2022.664420

3,618 views
11 citations

Review

Published on 27 Apr 2022

Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy

in Cancer Molecular Targets and Therapeutics

Wei Wang
Yue Sun
Xiaobo Liu
Shaji K. Kumar
Fengyan Jin
Yun Dai

Frontiers in Oncology

doi 10.3389/fonc.2022.859455

2,739 views
3 citations

Original Research

Published on 27 Apr 2022

Expression of CD274 mRNA Measured by qRT-PCR Correlates With PD-L1 Immunohistochemistry in Gastric and Urothelial Carcinoma

in Cancer Molecular Targets and Therapeutics

So Young Kang
You Jeong Heo
Ghee Young Kwon
Kyoung-Mee Kim

Frontiers in Oncology

doi 10.3389/fonc.2022.856444

3,888 views
6 citations

Original Research

Published on 27 Apr 2022

Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial

in Cancer Molecular Targets and Therapeutics

Qi Mei
Xiaoyu Li
Runkun Wang
Kai Qin
Yi Cheng
Weiting Cheng
Youhong Dong
Zhen He
Jun Li
Ming Li

Frontiers in Oncology

doi 10.3389/fonc.2022.820324

2,185 views
2 citations

Original Research

Published on 26 Apr 2022

A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors

in Cancer Molecular Targets and Therapeutics

Nagla Abdel Karim
Asad Ullah
Imran Ahmad
Elmustapha Bahassi
Olugbenga Olowokure
Ahmed Khaled
Harold Davis
John C. Morris

Frontiers in Oncology

doi 10.3389/fonc.2022.811411

2,317 views
2 citations

Review

Published on 25 Apr 2022

Clinical Efficacy and Potential Mechanisms of Acupoint Stimulation Combined With Chemotherapy in Combating Cancer: A Review and Prospects

in Cancer Molecular Targets and Therapeutics

Shanshan Li
Suhong Zhao
Yi Guo
Yuanzhen Yang
Jin Huang
Jiaqi Wang
Shanshan Lu
Bin Wang
Chao Chai
Zhifang Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.864046

6,443 views
11 citations

Correction

Published on 22 Apr 2022

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

in Cancer Molecular Targets and Therapeutics

Xu Zhang
Jie Wang
Yifeng Wang
Guanzheng Liu
Huan Li
Jiefeng Yu
Runqiu Wu
Jun Liang
Rutong Yu
Xuejiao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.911817

1,104 views

Mini Review

Published on 22 Apr 2022

Extracellular Vesicles and the Inflammasome: An Intricate Network Sustaining Chemoresistance

in Cancer Molecular Targets and Therapeutics

Letizia Mezzasoma
Ilaria Bellezza
Rita Romani
Vincenzo Nicola Talesa

Frontiers in Oncology

doi 10.3389/fonc.2022.888135

2,582 views
2 citations

Original Research

Published on 21 Apr 2022

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis

in Cancer Molecular Targets and Therapeutics

Shan-peng Liu
Xiao-min Li
Dan-man Liu
Shu-huan Xie
Shao-bo Zhang
Yu Li
Ze-feng Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.884448

4,009 views
6 citations

Review

Published on 21 Apr 2022

Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies

in Cancer Molecular Targets and Therapeutics

Nawar Al Nasrallah
Benjamin M. Wiese
Catherine R. Sears

Frontiers in Oncology

doi 10.3389/fonc.2022.846965

5,220 views
12 citations

Navigation group

Articles

Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC

Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential

A Combined Effect of G-Quadruplex and Neuro-Inducers as an Alternative Approach to Human Glioblastoma Therapy

Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression

Transfer RNA-Derived Small RNAs: Novel Regulators and Biomarkers of Cancers

Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases

Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy

Expression of CD274 mRNA Measured by qRT-PCR Correlates With PD-L1 Immunohistochemistry in Gastric and Urothelial Carcinoma

Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial

A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors

Clinical Efficacy and Potential Mechanisms of Acupoint Stimulation Combined With Chemotherapy in Combating Cancer: A Review and Prospects

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Extracellular Vesicles and the Inflammasome: An Intricate Network Sustaining Chemoresistance

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis

Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies